Search Page

1

Cite

Share

What would we do without metronidazole?

Stover KR, Riche DM, Gandy CL, Henderson H. Stover KR, et al. Among authors: riche dm. Am J Med Sci. 2012 Apr;343(4):316-9. doi: 10.1097/MAJ.0b013e3182254bd6. Am J Med Sci. 2012. PMID: 21817887 Review.

Cite

Share

2

Cite

Share

Infectious complications of newer agents in the fight against diabetes.

Stover KR, Hugh E, Sherman JJ, Malinowski SS, Berdahl GJ, Riche DM. Stover KR, et al. Among authors: riche dm. Nurse Pract. 2020 Nov;45(11):17-24. doi: 10.1097/01.NPR.0000718508.65708.a1. Nurse Pract. 2020. PMID: 33093391 Review.

Cite

Share

3

Cite

Share

Transdermal testosterone replacement therapy in men.

Ullah MI, Riche DM, Koch CA. Ullah MI, et al. Among authors: riche dm. Drug Des Devel Ther. 2014 Jan 9;8:101-12. doi: 10.2147/DDDT.S43475. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24470750 Free PMC article. Review.

Cite

Share

4

Cite

Share

New obesity agents: lorcaserin and phentermine/topiramate.

Fleming JW, McClendon KS, Riche DM. Fleming JW, et al. Among authors: riche dm. Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16. doi: 10.1345/aph.1R779. Epub 2013 Jun 25. Ann Pharmacother. 2013. PMID: 23800750 Review.

Cite

Share

5

Cite

Share

Orlistat: current status in clinical therapeutics.

McClendon KS, Riche DM, Uwaifo GI. McClendon KS, et al. Among authors: riche dm. Expert Opin Drug Saf. 2009 Nov;8(6):727-44. doi: 10.1517/14740330903321485. Expert Opin Drug Saf. 2009. PMID: 19998527 Review.

Cite

Share

6

Cite

Share

Pharmacologic therapy for nonalcoholic fatty liver disease in adults.

Malinowski SS, Byrd JS, Bell AM, Wofford MR, Riche DM. Malinowski SS, et al. Among authors: riche dm. Pharmacotherapy. 2013 Feb;33(2):223-42. doi: 10.1002/phar.1190. Epub 2013 Jan 28. Pharmacotherapy. 2013. PMID: 23359475 Review.

Cite

Share

7

Cite

Share

Frontline perspective on credentialing and privileging of ambulatory care pharmacists.

Weber ZA, Skelley JW, Riche DM, Bryant Shilliday B, Cavanaugh JJ, Foster K. Weber ZA, et al. Among authors: riche dm. Int J Pharm Pract. 2020 Aug;28(4):408-412. doi: 10.1111/ijpp.12619. Epub 2020 Mar 23. Int J Pharm Pract. 2020. PMID: 32202353

Cite

Share

8

Cite

Share

Canagliflozin, a novel SGLT2 inhibitor for treatment of type 2 diabetes.

Nigro SC, Riche DM, Pheng M, Baker WL. Nigro SC, et al. Among authors: riche dm. Ann Pharmacother. 2013 Oct;47(10):1301-11. doi: 10.1177/1060028013503626. Epub 2013 Oct 8. Ann Pharmacother. 2013. PMID: 24259694 Review.

Cite

Share

9

Cite

Share

Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis.

Sutton EE, Riche DM. Sutton EE, et al. Among authors: riche dm. Ann Pharmacother. 2012 Jul-Aug;46(7-8):1000-9. doi: 10.1345/aph.1Q543. Epub 2012 Jul 25. Ann Pharmacother. 2012. PMID: 22837347 Review.

Cite

Share

10

Cite

Share

Evidence-based review of statin use in patients with HIV on antiretroviral therapy.

Chastain DB, Stover KR, Riche DM. Chastain DB, et al. Among authors: riche dm. J Clin Transl Endocrinol. 2017 Feb 22;8:6-14. doi: 10.1016/j.jcte.2017.01.004. eCollection 2017 Jun. J Clin Transl Endocrinol. 2017. PMID: 29067253 Free PMC article. Review.

Cite

Share